デフォルト表紙
市場調査レポート
商品コード
1619216

血液検査の市場規模、シェア、成長分析、タイプ別、方法別、エンドユーザー別、地域別- 産業予測、2024~2031年

Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血液検査の市場規模、シェア、成長分析、タイプ別、方法別、エンドユーザー別、地域別- 産業予測、2024~2031年
出版日: 2024年12月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血液検査の世界市場規模は、2022年に956億5,000万米ドルと評価され、2023年の1,034億9,000万米ドルから2031年には1,944億2,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは8.2%で成長する見通しです。

世界の血液検査市場は、政府部門と民間部門の両方による医療支出の増加により、大きな成長を遂げると予測されています。多国籍医療機関は、革新的な技術を積極的に開発し、慢性疾患に対する意識を高めており、血液検査の需要をさらに促進しています。2031年までに7億8,300万人の成人が罹患すると予想される糖尿病を中心とする慢性疾患の増加は、健康評価製品に対する大きな需要を生み出します。CMSやFDAのような規制機関は、疾病の早期発見を強化するCLIA準拠の診断検査を推進する上で極めて重要です。このような規制当局の支援の急増と健康への関心の高まりは、血液検査分野の事業全体に有利な機会を提供し、今後数年間の市場の堅調な拡大を位置付けています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • ケーススタディ
  • 特許分析

血液検査の市場規模:タイプ別& CAGR(2024-2031)

  • 市場概要
  • グルコース検査
  • 脂質パネル検査
  • 前立腺特異抗原(PSA)検査
  • 血中尿素窒素(BUN)検査
  • 甲状腺刺激ホルモン検査
  • その他のタイプ
    • 直接LDL検査
    • テストステロン検査

血液検査の市場規模:方法別& CAGR(2024-2031)

  • 市場概要
  • マニュアル血液検査
  • 自動血液検査

血液検査の市場規模:エンドユーザー別& CAGR(2024-2031)

  • 市場概要
  • 診断検査室
  • 病院
  • その他のエンドユーザー

血液検査の市場規模:地域別& CAGR(2024-2031)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • bioMerieux
  • Quest Diagnostics Incorporated
  • Biomerica
  • BD
  • Siemens Healthineers AG
  • Danaher Corporation
  • Trinity Biotech Plc
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Dr Lal PathLabs Limited
  • Alere Inc.
  • Cepheid Corporation

結論と推奨事項

目次
Product Code: SQMIG35A2519

Global Blood Testing Market size was valued at USD 95.65 billion in 2022 and is poised to grow from USD 103.49 billion in 2023 to USD 194.42 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global blood testing market is projected to experience significant growth, fueled by increasing medical expenditures from both government and private sectors. Multinational healthcare organizations are actively developing innovative techniques and raising awareness about chronic diseases, further driving demand for blood testing. The rise in chronic disease prevalence, especially diabetes-expected to affect 783 million adults by 2031-will create substantial demand for health assessment products. Regulatory bodies like CMS and FDA are pivotal in promoting CLIA-compliant diagnostic tests that enhance early disease detection. This surge in regulatory support and rising health concerns offers lucrative opportunities for operational entities within the blood testing sector, positioning it for robust market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Testing Market Segmental Analysis

Global Blood Testing Market is segmented by type, methods, end user and region. Based on type, the market is segmented into glucose testing, lipid panel testing, prostate specific antigen (PSA) testing, blood urea nitrogen (BUN) testing, thyroid stimulating hormone testing and other types (Direct LDL Testing, Testosterone Testing). Based on methods, the market is segmented into manual blood testing and automated blood testing. Based on end user, the market is segmented into diagnostic laboratories, hospitals and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Testing Market

The Global Blood Testing market is significantly influenced by several key drivers that contribute to its growth. One of the most crucial factors is the influx of external funding directed towards clinical studies focused on innovating advanced diagnostic technologies. Additionally, as patient awareness regarding various self-testing and home diagnostic options rises, this trend is expected to further boost the market. Moreover, the increasing prevalence of chronic diseases, coupled with a heightened demand for rapid health assessment products, suggests a strong upward trajectory for the global blood testing market in the upcoming years. These elements collectively create a favorable environment for market expansion.

Restraints in the Global Blood Testing Market

The Global Blood Testing market faces significant challenges that may impede its growth, particularly in developing nations like India, Indonesia, and Malaysia. A key restraint is the limited awareness among patients regarding advanced technological devices, which can inhibit adoption rates. Additionally, the high costs associated with these devices and self-testing kits are anticipated to further suppress market demand in the foreseeable future. These factors collectively contribute to a slower market advancement, highlighting the need for increased education and more affordable options to enhance accessibility and utilization of blood testing technologies in these regions.

Market Trends of the Global Blood Testing Market

The global blood testing market is witnessing significant growth driven by advancements in technology and a surge in demand for accurate diagnostic solutions. Key players are increasingly leveraging innovations, particularly Artificial Intelligence, to enhance the precision and speed of disease detection, enabling early intervention and improved patient outcomes. This focus on integrating cutting-edge technologies not only streamlines testing processes but also caters to the evolving needs of healthcare providers and patients alike. As a result, the market is poised for expansion, with a notable emphasis on developing user-friendly products that enhance accessibility and efficiency, thereby reshaping the landscape of blood diagnostics worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies
  • Patent Analysis

Global Blood Testing Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Glucose Testing
  • Lipid Panel Testing
  • Prostate Specific Antigen (PSA) Testing
  • Blood Urea Nitrogen (BUN) Testing
  • Thyroid Stimulating Hormone Testing
  • Other Types
    • Direct LDL Testing
    • Testosterone Testing

Global Blood Testing Market Size by Methods & CAGR (2024-2031)

  • Market Overview
  • Manual Blood Testing
  • Automated Blood Testing

Global Blood Testing Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

Global Blood Testing Market Size & CAGR (2024-2031)

  • North America (Type, Methods, End User)
    • USA
    • Canada
  • Europe (Type, Methods, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Methods, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Methods, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Methods, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerica
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr Lal PathLabs Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations